OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Alexandra L. Whittaker, Rebecca P. George, Lucy O’Malley
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Showing 1-25 of 105 citing articles:
Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Efficacy of Progressive Muscle Relaxation in Adults for Stress, Anxiety, and Depression: A Systematic Review
Syazwina Muhammad Khir, Wan Mohd Azam Wan Mohd Yunus, Norashikin Mahmud, et al.
Psychology Research and Behavior Management (2024) Vol. Volume 17, pp. 345-365
Open Access | Times Cited: 20
Syazwina Muhammad Khir, Wan Mohd Azam Wan Mohd Yunus, Norashikin Mahmud, et al.
Psychology Research and Behavior Management (2024) Vol. Volume 17, pp. 345-365
Open Access | Times Cited: 20
Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
Nusrat Jan, Shazia Sofi, Hina Qayoom, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24670-e24670
Open Access | Times Cited: 14
Nusrat Jan, Shazia Sofi, Hina Qayoom, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24670-e24670
Open Access | Times Cited: 14
Omid Amani, Mohammad Ali Mazaheri, Mona Malekzadeh, et al.
Cancer Reports (2024) Vol. 7, Iss. 2
Open Access | Times Cited: 12
Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)
Stephen R. Rapp, Emily V. Dressler, W. Mark Brown, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 21, pp. 2546-2557
Closed Access | Times Cited: 7
Stephen R. Rapp, Emily V. Dressler, W. Mark Brown, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 21, pp. 2546-2557
Closed Access | Times Cited: 7
Cognitive impairment following breast cancer treatments: an umbrella review
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
Giulia Oliva, Andreina Giustiniani, Laura Danesin, et al.
The Oncologist (2024) Vol. 29, Iss. 7, pp. e848-e863
Open Access | Times Cited: 7
Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
Lauren Otto, Corena V. Grant, Ashley A. Lahoud, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 208-220
Closed Access | Times Cited: 6
Lauren Otto, Corena V. Grant, Ashley A. Lahoud, et al.
Brain Behavior and Immunity (2024) Vol. 120, pp. 208-220
Closed Access | Times Cited: 6
The prevalence of adolescent pregnancy and its associated consequences in the Eastern Mediterranean region: a systematic review and meta-analysis
Mehdi Varmaghani, Asma Pourtaheri, Hamideh Ahangari, et al.
Reproductive Health (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Mehdi Varmaghani, Asma Pourtaheri, Hamideh Ahangari, et al.
Reproductive Health (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis
David E. Hinojosa‐Gonzalez, Affan Zafar, Gal Saffati, et al.
Prostate Cancer and Prostatic Diseases (2024) Vol. 27, Iss. 3, pp. 507-519
Open Access | Times Cited: 5
David E. Hinojosa‐Gonzalez, Affan Zafar, Gal Saffati, et al.
Prostate Cancer and Prostatic Diseases (2024) Vol. 27, Iss. 3, pp. 507-519
Open Access | Times Cited: 5
Subjective cognitive functioning in patients with cancer: A network approach
Gabriel Baník, Ivana Piterová, Matúš Adamkovič, et al.
Journal of Psychosocial Oncology (2025), pp. 1-22
Closed Access
Gabriel Baník, Ivana Piterová, Matúš Adamkovič, et al.
Journal of Psychosocial Oncology (2025), pp. 1-22
Closed Access
Effects of non-pharmacological interventions on cancer-related cognitive impairment in patients with breast cancer: A systematic review and network meta-analysis
Pan Yang, Qian Hu, Lichuan Zhang, et al.
European Journal of Oncology Nursing (2025), pp. 102804-102804
Closed Access
Pan Yang, Qian Hu, Lichuan Zhang, et al.
European Journal of Oncology Nursing (2025), pp. 102804-102804
Closed Access
Perceived stress and cognitive function in breast cancer chemotherapy patients: A latent profile analysis
Xiaotong Ding, Hongli Chen, Houming Kan, et al.
European Journal of Oncology Nursing (2025), pp. 102867-102867
Closed Access
Xiaotong Ding, Hongli Chen, Houming Kan, et al.
European Journal of Oncology Nursing (2025), pp. 102867-102867
Closed Access
Pilot randomized study of adaptive cognitive training’s effect on breast cancer survivors assessed through eye tracking
Yuxin Huang, Ze Yu, Youyang Wang, et al.
Journal of Cancer Survivorship (2025)
Open Access
Yuxin Huang, Ze Yu, Youyang Wang, et al.
Journal of Cancer Survivorship (2025)
Open Access
Neurological Complications of Conventional and Novel Anticancer Treatments
Paola Alberti, Alessandro Salvalaggio, Andreas A. Argyriou, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6088-6088
Open Access | Times Cited: 21
Paola Alberti, Alessandro Salvalaggio, Andreas A. Argyriou, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6088-6088
Open Access | Times Cited: 21
Psychological distress is involved in CRCI in breast cancer survivors via mediating cytokine levels
Lulian Pang, Wen Li, Senbang Yao, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11806-11815
Open Access | Times Cited: 11
Lulian Pang, Wen Li, Senbang Yao, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11806-11815
Open Access | Times Cited: 11
Effects of exercise on cancer-related cognitive impairment in breast cancer survivors: a scoping review
Orellana-Jaén Jesús, Luís Carrasco Páez, Matilde Mora Fernández
Breast Cancer (2023) Vol. 30, Iss. 6, pp. 885-909
Open Access | Times Cited: 11
Orellana-Jaén Jesús, Luís Carrasco Páez, Matilde Mora Fernández
Breast Cancer (2023) Vol. 30, Iss. 6, pp. 885-909
Open Access | Times Cited: 11
A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?
Marianne Merceur, Karen T. Reilly, I. Bonan, et al.
Annals of Physical and Rehabilitation Medicine (2024) Vol. 67, Iss. 5, pp. 101832-101832
Open Access | Times Cited: 4
Marianne Merceur, Karen T. Reilly, I. Bonan, et al.
Annals of Physical and Rehabilitation Medicine (2024) Vol. 67, Iss. 5, pp. 101832-101832
Open Access | Times Cited: 4
The association between neuropsychological impairment, self-perceived cognitive deficit, symptoms, and health related quality of life in newly diagnosed ovarian cancer patients
Liying Wang, Yan Ding, Yi Zhang, et al.
Asia-Pacific Journal of Oncology Nursing (2024) Vol. 11, Iss. 5, pp. 100447-100447
Open Access | Times Cited: 4
Liying Wang, Yan Ding, Yi Zhang, et al.
Asia-Pacific Journal of Oncology Nursing (2024) Vol. 11, Iss. 5, pp. 100447-100447
Open Access | Times Cited: 4
Global Prevalence of Mental Health Problems Among Cancer Survivors: A Meta‐Analysis From 31 Countries
Meng‐Wei Ge, Jun Sheng, Lu‐Ting Shen, et al.
Psycho-Oncology (2025) Vol. 34, Iss. 1
Closed Access
Meng‐Wei Ge, Jun Sheng, Lu‐Ting Shen, et al.
Psycho-Oncology (2025) Vol. 34, Iss. 1
Closed Access
The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: A Qualitative Systematic Review (Preprint)
Maryam Ibrar, Harleen Kaur, Ashleigh Main, et al.
(2025)
Closed Access
Maryam Ibrar, Harleen Kaur, Ashleigh Main, et al.
(2025)
Closed Access
Defining brain fog across medical conditions
Peter Denno, Sijia Zhao, Masud Husain, et al.
Trends in Neurosciences (2025)
Open Access
Peter Denno, Sijia Zhao, Masud Husain, et al.
Trends in Neurosciences (2025)
Open Access
Advances in risk prediction models for cancer-related cognitive impairment
Ran Duan, ZuJun Wen, Ting Zhang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
Ran Duan, ZuJun Wen, Ting Zhang, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access
α-Bisabolol alleviates doxorubicin-induced cognitive dysfunction in rats via enhancing the hippocampal BDNF/TrKB signaling and inhibiting neuroinflammation
Sara T. Elazab, Walter H. Hsu
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Sara T. Elazab, Walter H. Hsu
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Chemotherapy-related cognitive impairment and kidney dysfunction
Mariadelina Simeoni, Michele M. Mulholland, Biruh Workeneh, et al.
Nephrology Dialysis Transplantation (2025) Vol. 40, Iss. Supplement_2, pp. ii54-ii63
Open Access
Mariadelina Simeoni, Michele M. Mulholland, Biruh Workeneh, et al.
Nephrology Dialysis Transplantation (2025) Vol. 40, Iss. Supplement_2, pp. ii54-ii63
Open Access
The role of oxytocin in mediating the relationships between social factors and chemotherapy-associated cognitive decline in female patients with breast cancer
Melina Seng, Seth Adarkwah Yiadom, Lauren Otto, et al.
Psychoneuroendocrinology (2025) Vol. 176, pp. 107428-107428
Open Access
Melina Seng, Seth Adarkwah Yiadom, Lauren Otto, et al.
Psychoneuroendocrinology (2025) Vol. 176, pp. 107428-107428
Open Access
